Cargando…
4‐octyl itaconate improves the viability of D66H cells by regulating the KEAP1‐NRF2‐GCLC/HO‐1 pathway
As a novel nuclear factor E2‐related factor 2 (NRF2) activator, the itaconate has shown significant therapeutic potential for oxidative stress diseases. However, its role in Vohwinkel syndrome in relation to the gap junction protein beta 2 (GJB2) mutation is still unclear. This study aimed at invest...
Autores principales: | Chen, Yanrui, Wang, Zhenying, Song, Yali, Chen, Nan, Guo, Jing, Liu, Wenmin, Guo, Keying, Ling, Xia, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064036/ https://www.ncbi.nlm.nih.gov/pubmed/36916028 http://dx.doi.org/10.1111/jcmm.17708 |
Ejemplares similares
-
Four-octyl itaconate activates Keap1-Nrf2 signaling to protect neuronal cells from hydrogen peroxide
por: Liu, Hua, et al.
Publicado: (2018) -
Four-Octyl itaconate ameliorates periodontal destruction via Nrf2-dependent antioxidant system
por: Xin, Liangjing, et al.
Publicado: (2022) -
4‐octyl Itaconate inhibits lipopolysaccharide (LPS)‐induced osteoarthritis via activating Nrf2 signalling pathway
por: Zhang, Qingchen, et al.
Publicado: (2022) -
Four-Octyl Itaconate Attenuates UVB-Induced Melanocytes and Keratinocytes Apoptosis by Nrf2 Activation-Dependent ROS Inhibition
por: Xie, Yongyi, et al.
Publicado: (2022) -
4-Octyl Itaconate and Dimethyl Fumarate Induce Secretion of the Anti-Inflammatory Protein Annexin A1 via NRF2
por: Diskin, Ciana, et al.
Publicado: (2023)